Toviaz 4 mg, tablet met verlengde afgifte

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/toviaz-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Fesoterodine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73203",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "GLYCEROLDIBEHENAAT",
    "HYPROMELLOSE 2208 (Release controlling polymer), K100M (E 464)",
    "HYPROMELLOSE 2208 (Release controlling polymer), K4M (E 464)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 1-WATER",
    "LECITHINE, SOYA (E 322)",
    "MACROGOL 3350",
    "POLYVINYLALCOHOL (E 1203)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "XYLITOL (E 967)"
  ],
  "substances": [
    "FESOTERODINEFUMARAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2007/04/20",
  "procedure_number": "EMEA/H/C/000723",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/07/386",
  "additional_monitoring": "N"
}